Table 8.6d

Immunosuppression Use for Maintenance by Regimen

Prior to Discharge, 1995 to 2004

Recipients with Kidney-Pancreas Transplants

  Transplant Year
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Functioning Graft at Discharge 894 835 823 933 908 887 862 877 846 862
With Immunosuppression Info 893 835 823 933 908 885 861 877 843 829
--- + MMF/MPA 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 1.1% 2.1%
--- + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 2.4% 4.6%
--- + MMF/MPA + Steroids 0.9% 1.6% 1.2% 1.2% 1.1% 0.5% 0.8% 0.5% 0.8% 1.3%
--- + OtherAntimet 0.8% 0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
--- + OtherAntimet + Steroids 4.0% 1.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
--- + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.1%
--- + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.2% 0.2% 0.2%
--- + Steroids 1.7% 0.8% 0.6% 0.6% 2.2% 1.4% 0.1% 0.5% 1.7% 0.8%
CyA 0.3% 0.0% 0.1% 0.1% 0.0% 0.1% 0.0% 0.0% 0.0% 0.1%
CyA + MMF/MPA 0.9% 1.3% 0.5% 0.0% 0.2% 0.0% 0.0% 0.0% 0.4% 0.2%
CyA + MMF/MPA + OtherAntimet 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
CyA + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0%
CyA + MMF/MPA + Steroids 13.9% 37.8% 34.1% 24.3% 18.9% 12.2% 8.5% 7.0% 5.0% 1.4%
CyA + OtherAntimet 2.8% 0.2% 0.2% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0%
CyA + OtherAntimet + Steroids 31.4% 9.5% 2.2% 0.8% 0.1% 0.2% 0.1% 0.0% 0.0% 0.1%
CyA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.3% 2.9%
CyA + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.1% 0.0% 2.6% 1.6% 0.6% 1.8% 1.0%
CyA + Steroids 2.7% 2.4% 1.8% 0.8% 0.6% 0.5% 0.3% 0.1% 0.0% 0.0%
Tac 0.9% 0.2% 0.1% 0.0% 0.8% 0.9% 1.4% 2.4% 1.1% 3.3%
Tac + MMF/MPA 0.1% 0.8% 0.6% 1.4% 1.2% 1.4% 0.8% 1.4% 4.0% 6.4%
Tac + MMF/MPA + OtherAntimet 0.1% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Tac + MMF/MPA + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 1.5% 2.1% 2.1% 1.0%
Tac + MMF/MPA + Steroids 5.3% 23.5% 42.5% 56.3% 64.0% 63.6% 61.3% 65.8% 62.4% 65.3%
Tac + OtherAntimet 1.5% 0.0% 0.0% 0.1% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Tac + OtherAntimet + Steroids 17.9% 6.0% 1.7% 1.7% 1.1% 1.1% 0.1% 0.6% 0.7% 0.2%
Tac + Siro/Evero 0.0% 0.0% 0.0% 0.0% 0.0% 0.5% 1.7% 4.9% 3.6% 3.4%
Tac + Siro/Evero + Steroids 0.0% 0.0% 0.0% 0.0% 0.7% 6.7% 11.1% 6.8% 4.9% 2.3%
Tac + Steroids 4.9% 4.1% 2.4% 2.9% 2.9% 1.7% 2.4% 1.5% 2.5% 1.4%
Other Regimen 10.0% 10.4% 11.7% 9.5% 6.3% 6.7% 7.9% 5.7% 4.2% 1.8%


Source: OPTN/SRTR Data as of May 2, 2005.

Percentages in each column sum to 100 percent.

---: No Calcineurin Inhibitor Use; CyA: Cyclosporine; Tac: Tacrolimus.

MMF: Mycophenolate Mofetil; MPA: Mycophenolate Sodium; Siro: Sirolimus; Evero: Everolimus; OtherAntimet: Antimetabolites excluding MMF and MPA.

"Other Regimen" includes drug combinations that are different from the listed regimens and drugs from the text field entering.